BTAI
BTAI
NASDAQ · Biotechnology

Bioxcel Therapeutics Inc

$0.01
0.00 (-12.00%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +249,445.5% upside
Low Target $14.05
Average Target $21.96
High Target $26.87
Current Price $0.01
Current
$0.01
Target
$21.96
$14.05 $21.96 avg $26.87
Scenario Analysis
Bear Case
$14.05
159,559.1%
Low target
Base Case
$21.96
+249,445.5%
Avg target
Bull Case
$26.87
+305,240.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
Target vs 52W High
$21.96
+842.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%